Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
solabegron (3 trials)
Urinary Bladder, Overactive (Phase 2)
Trials (3 total)
Trial APIs (1 total)